1. Park DK, Um SH, Lee JW, et al. Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices. J Gastroenterol Hepatol. 2004; 19:1042–1051.
Article
2. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007; 46:922–938.
Article
3. Huang YH, Yeh HZ, Chen GH, et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc. 2000; 52:160–167.
Article
4. Kim YS, Cho SW, Hahm KB, et al. Esophagus, stomach & intestine; hemostatic effect of histoacryl for band: induced esophageal ulcer bleeding. Korean J Gastrointest Endosc. 1997; 17:119–124.
5. Lee GH, Shin YJ, Ko YY, et al. N-utyl–yanoacrylate (Histoacryl) in the treatment of esophageal variceal bleeding: comparison with band ligation. Korean J Hepatol. 1999; 5:306–313.
6. Naga M, Foda A. An unusual complication of histoacryl injection. Endoscopy. 1997; 29:140.
Article
7. Tan YM, Goh KL, Kamarulzaman A, et al. Multiple systemic embo-lisms with septicemia after gastric variceal obliteration with cyanoacrylate. Gastrointest Endosc. 2002; 55:276–278.
Article
8. Park WG, Yeh RW, Triadafilopoulos G. Injection therapies for variceal bleeding disorders of the GI tract. Gastrointest Endosc. 2008; 67:313–323.
Article
9. Petersen B, Barkun A, Carpenter S, et al. Tissue adhesives and fibrin glues. Gastrointest Endosc. 2004; 60:327–333.
Article
10. D'Imperio N, Piemontese A, Baroncini D, et al. Evaluation of un-diluted N-butyl-2-cyanoacrylate in the endoscopic treatment of upper gastrointestinal tract varices. Endoscopy. 1996; 28:239–243.
11. Oho K, Iwao T, Sumino M, Toyonaga A, Tanikawa K. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy. 1995; 27:349–354.
Article
12. Lux G, Retterspitz M, Stabenow-Lohbauer U, Langer M, Altendorf-Hofmann A, Bozkurt T. Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidoca-nol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver. Endoscopy. 1997; 29:241–246.
Article
13. Thakeb F, Salama Z, Salama H, Abdel Raouf T, Abdel Kader S, Abdel Hamid H. The value of combined use of N-butyl-2-cyanoa-crylate and ethanolamine oleate in the management of bleeding esophagogastric varices. Endoscopy. 1995; 27:358–364.
Article
14. Feretis C, Dimopoulos C, Benakis P, Kalliakmanis B, Apostolidis N. N-butyl-2-cyanoacrylate (Histoacryl) plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding esophageal varices: a randomized prospective study. Endoscopy. 1995; 27:355–357.
Article
15. Jutabha R, Jensen DM, Egan J, Machicado GA, Hirabayashi K. Randomized, prospective study of cyanoacrylate injection, sclerotherapy, or rubber band ligation for endoscopic hemostasis of bleeding canine gastric varices. Gastrointest Endosc. 1995; 41:201–205.
Article
16. Evrard S, Dumonceau JM, Delhaye M, Golstein P, Devière J, Le Moine O. Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial. Endoscopy. 2003; 35:729–735.
Article
17. Wai CT, Sutedja DS, Khor CJ, Teoh KF, Yeoh KG. Esophageal sinus formation as a complication of cyanoacrylate injection. Gastrointest Endosc. 2005; 61:773–775.
Article